@article{f718ed57faa44be28524a480d0287bee,
title = "Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy",
author = "\{PSO-BIO-COVID study group\} and M. Talamonti and M. Galluzzo and A. Chiricozzi and P. Quaglino and G. Fabbrocini and P. Gisondi and Marzano, \{A. V.\} and C. Potenza and A. Conti and A. Parodi and \{Belloni Fortina\}, A. and F. Bardazzi and G. Argenziano and F. Rongioletti and L. Stingeni and G. Micali and F. Loconsole and M. Venturini and Bongiorno, \{M. R.\} and C. Feliciani and P. Rubegni and P. Amerio and Fargnoli, \{M. C.\} and P. Pigatto and P. Savoia and Nistic{\`o}, \{S. P.\} and S. Giustini and A. Carugno and Cannav{\`o}, \{S. P.\} and G. Rech and F. Prignano and A. Offidani and M. Lombardo and I. Zalaudek and L. Bianchi and K. Peris and R. Balestri and N. Bernardini and E. Botti and M. Burlando and G. Caldarola and A. Cattaneo and P. Dapavo and S. Dastoli and \{De Simone\}, C. and \{Di Nuzzo\}, S. and F. Diotallevi and Fierro, \{M. T.\} and R. Fidanza and C. Foti",
note = "Funding Information: L. Bianchi reports personal fees from speaker and as consultant for AbbVie, Novartis, Janssen‐Cilag, Pfizer, UCB and Leo Pharma, outside the submitted work. SP Cannav{\`o} has served as speaker or board member for AbbVie, Celgene, Eli Lilly, Leo Pharma, Janssen, Novartis and Sanofi Genzyme. A. Chiricozzi served as advisory board member and consultant and has received fees and speaker's honoraria or has participated in clinical trials for AbbVie, Almirall, Biogen, Fresenius Kabi, Leo Pharma, Lilly, Janssen, Novartis, Sanofi Genzyme and UCB Pharma. A. Conti served as advisory board member and consultant, and has received fees and speaker{\textquoteright}s honoraria or has participated in clinical trials for AbbVie, Leo Pharma, Eli Lilly, Novartis, UCB Pharma, Pfizer, Sandoz, Celgene, Biogen and Janssen‐Cilag. M.C. Fargnoli has served on advisory boards, received honoraria for lectures and research grants from Almirall, AbbVie, Galderma, Leo Pharma, Mylan, Medac Pharma, Celgene, Pierre Fabre, UCB, Eli Lilly, Pfizer, Janssen, Novartis, Sanofi Genzyme, Roche, Sun Pharma and MSD. P. Gisondi has been a consultant and/or speaker for AbbVie, Almirall, Celgene, Janssen, Leo pharma, Eli Lilly, Novartis, Pfizer, Sandoz and UCB. K. Peris reports personal fees for advisory board meeting from Almirall, AbbVie, Biogen, Janssen, Eli Lilly, Celgene, Galderma, Leo Pharma, Novartis, Pierre Fabre, Sanofi, Sandoz and Sun Pharma outside the conduct of the work. I. Zalaudek has been a consultant and/or speaker for Novartis, Celgene and Amgen. ",
year = "2020",
month = dec,
doi = "10.1111/jdv.16841",
language = "English",
volume = "34",
pages = "e770--e772",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "John Wiley and Sons Inc.",
number = "12",
}
SDG 3 Salute e benessere